These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 18755869
1. Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain. Sabio JM, Zamora-Pasadas M, Jiménez-Jáimez J, Albadalejo F, Vargas-Hitos J, Rodríguez del Aguila MD, Hidalgo-Tenorio C, Gonzalez-Gay MA, Jimenez-Alonso J. Lupus; 2008 Sep; 17(9):849-59. PubMed ID: 18755869 [Abstract] [Full Text] [Related]
2. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study. Bessant R, Duncan R, Ambler G, Swanton J, Isenberg DA, Gordon C, Rahman A. Arthritis Rheum; 2006 Dec 15; 55(6):892-9. PubMed ID: 17139666 [Abstract] [Full Text] [Related]
3. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus. Zonana-Nacach A, Santana-Sahagún E, Jiménez-Balderas FJ, Camargo-Coronel A. J Clin Rheumatol; 2008 Apr 15; 14(2):74-7. PubMed ID: 18391674 [Abstract] [Full Text] [Related]
4. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD. J Clin Rheumatol; 2009 Apr 15; 15(3):111-6. PubMed ID: 19300290 [Abstract] [Full Text] [Related]
5. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients. Yang L, Tao J, Tang X, Wang Y, He X, Xu G, Ren Y, Tu Y. J Eur Acad Dermatol Venereol; 2012 Jan 15; 26(1):95-101. PubMed ID: 21851424 [Abstract] [Full Text] [Related]
8. Metabolic syndrome in Chinese patients with systemic lupus erythematosus: no association with plasma cortisol level. Liu SY, Han LS, Guo JY, Zheng ZH, Li H, Zhang L, Zhang X, He YJ, Gao GM, Liu ZS, Zeng XF. Lupus; 2013 Apr 15; 22(5):519-26. PubMed ID: 23554041 [Abstract] [Full Text] [Related]
9. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study. Fiuza M, Cortez-Dias N, Martins S, Belo A, VALSIM study investigators. Rev Port Cardiol; 2008 Dec 15; 27(12):1495-529. PubMed ID: 19280993 [Abstract] [Full Text] [Related]
10. Prevalence of and factors associated with hypertension in young and old women with systemic lupus erythematosus. Sabio JM, Vargas-Hitos JA, Navarrete-Navarrete N, Mediavilla JD, Jiménez-Jáimez J, Díaz-Chamorro A, Jiménez-Alonso J, Grupo Lupus Virgen de las Nieves. J Rheumatol; 2011 Jun 15; 38(6):1026-32. PubMed ID: 21406497 [Abstract] [Full Text] [Related]
11. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients. Bahrehmand F, Vaisi-Raygani A, Kiani A, Rahimi Z, Tavilani H, Navabi SJ, Shakiba E, Hassanzadeh N, Pourmotabbed T. Lupus; 2012 May 15; 21(6):616-24. PubMed ID: 22323339 [Abstract] [Full Text] [Related]
12. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study. Martínez MA, Puig JG, Mora M, Aragón R, O'Dogherty P, Antón JL, Sánchez-Villares T, Rubio JM, Rosado J, Torres R, Marcos J, Pallardo LF, Banegas JR, MAPA (Monitorización Ambulatoria de la Presión Arterial) Working Group. Metabolism; 2008 Sep 15; 57(9):1232-40. PubMed ID: 18702949 [Abstract] [Full Text] [Related]
13. Frequency of adverse drug reactions in patients with systemic lupus erythematosus. Pope J, Jerome D, Fenlon D, Krizova A, Ouimet J. J Rheumatol; 2003 Mar 15; 30(3):480-4. PubMed ID: 12610805 [Abstract] [Full Text] [Related]
14. Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics. Telles R, Lanna C, Ferreira G, Ribeiro A. Lupus; 2010 Jun 15; 19(7):803-9. PubMed ID: 20118159 [Abstract] [Full Text] [Related]
15. Inflammatory biomarkers and oxidative stress measurements in patients with systemic lupus erythematosus with or without metabolic syndrome. Lozovoy MA, Simão AN, Hohmann MS, Simão TN, Barbosa DS, Morimoto HK, Reiche EM, Cecchini R, Dichi I. Lupus; 2011 Nov 15; 20(13):1356-64. PubMed ID: 21868433 [Abstract] [Full Text] [Related]
17. [Cardiovascular risk profile in systemic lupus erythematosus: a cross-sectional study of 879 patients]. He CS, Shi W, Ye ZM, Liang XL, Zhang B, Liu SX. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov 15; 31(11):1910-3. PubMed ID: 22126778 [Abstract] [Full Text] [Related]
19. Association between dental caries and pneumonia in patients with systemic lupus erythematosus. Pascual-Ramos V, Hernández-Hernández C, Soto-Rojas AE, Celis-Aguilar E, Sánchez-Guerrero J. J Rheumatol; 2006 Oct 15; 33(10):1996-2002. PubMed ID: 16960926 [Abstract] [Full Text] [Related]
20. Risk factors for development of coronary artery disease in women with systemic lupus erythematosus. Goldberg RJ, Urowitz MB, Ibañez D, Nikpour M, Gladman DD. J Rheumatol; 2009 Nov 15; 36(11):2454-61. PubMed ID: 19833754 [Abstract] [Full Text] [Related] Page: [Next] [New Search]